Skip to main content

Table 1 Characteristics of Study Samples

From: Rural-urban disparities in preventive breast and cervical cancer screening among women with early-onset dementia

 

Mammogram Sample

Pap Smear Sample

 

Total

ADRD/CI

non-ADRD/CI

Total

ADRD/CI

non-ADRD/CI

Preventive Cancer Screening Compliance, %

68.50

63.97

68.51

62.72

55.41

62.74

Having ADRD/CI, %

0.28

100

0

0.23

100

0

Rural, %

14.61

13.61

14.62

13.48

12.97

13.48

Age, mean (SD), years

56.52 (4.03)

57.99 (3.98)

56.51 (4.03)

52.37 (6.81)

55.79 (6.22)

52.36 (6.81)

Age 40–44, %

N/A

N/A

N/A

16.92

6.97

16.94

Age 45–49, %

N/A

N/A

N/A

19.02

10.81

19.04

Age 50–54, %

35.54

22.79

35.58

21.86

18.23

21.87

Age 55–59, %

36.47

34.63

36.47

23.43

28.37

23.42

Age 60–64, %

27.99

42.58

27.95

18.77

35.63

18.73

Charlson Comorbidity Index, mean (SD)

0.57 (1.21)

1.64 (2.24)

0.57 (1.20)

0.49 (1.12)

1.60 (2.23)

0.49 (1.12)

Insurance plan type, %

--

--

--

--

--

--

Comprehensive

4.12

6.81

4.11

3.47

6.48

3.46

HMO

11.22

10.29

11.22

10.97

9.50

10.98

PPO

59.41

58.61

59.41

57.50

57.43

57.50

POS

7.95

8.43

7.95

7.61

8.42

7.61

HDHP/CDHP

16.15

14.76

16.16

19.44

17.16

19.44

EPO

1.15

1.10

1.15

1.01

1.01

1.01

Unique Individuals, n a

6,349,308

36,131

6,340,838

6,583,088

30,919

6,575,926

Observations, n, person-years b

16,644,386

46,246

16,598,140

16,605,918

38,704

16,567,214

  1. Abbreviations: ADRD, Alzheimer’s disease and related dementias; CI, cognitive impairment; EPO, exclusive provider organization; HMO, health maintenance organization; POS, point of service; PPO, preferred provider organization; HDHP, high deductible health plan; CDHP, consumer directed health plan
  2. a The sum of unique individuals in each group (ADRD/CI and non-ADRD/CI) is greater than the sample total because some individuals developed ADRD/CI during the study period
  3. b Person-year observations are the denominator for descriptive statistics